Proteomics approaches to characterize the immune responses in cancer
Urbiola-Salvador, Víctor; Miroszewska, Dominika; Jabłońska, Agnieszka; Qureshi, Talha; Chen, Zhi (2022-04-04)
Urbiola-Salvador, V., Miroszewska, D., Jabłońska, A., Qureshi, T., & Chen, Z. (2022). Proteomics approaches to characterize the immune responses in cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1869(8), 119266. https://doi.org/10.1016/j.bbamcr.2022.119266
© 2022 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
https://creativecommons.org/licenses/by-nc-nd/4.0/
https://urn.fi/URN:NBN:fi-fe2022090857825
Tiivistelmä
Abstract
Despite the dynamic development of cancer research, annually millions of people die of cancer. The human immune system is the major ‘guard’ against tumor development. Unfortunately, cancer cells have the ability to evade the immune system and continue to grow. The proper understanding of the intricate immune response in tumorigenesis remains the holy grail of cancer immunology and designing effective immunotherapy. To decode the immune responses in cancer, in recent years, proteomics studies have received considerable attention. Proteomics studies focus on the detection and quantification of proteins, which are the effectors of biological functions, and as such, are proven to reflect the cell state more accurately, in comparison to genomic or transcriptomic studies. In this review, we discuss the proteomics studies applied to characterize the immune responses in cancer and tumor immune microenvironment heterogeneity. Further, we describe emerging single-cell proteomics approaches that have the potential to be applied in cancer immunity studies.
Kokoelmat
- Avoin saatavuus [31941]